Navigation Links
USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration

The U.S. Pharmacopeial (USP) Convention is pleased to announce that Matthew Heyman joined the organization as vice president of external affairs and strategic integration on December 1, 2008.

Rockville, Md. (Vocus) December 1, 2008 -- The U.S. Pharmacopeial (USP) Convention is pleased to announce that Matthew Heyman joined the organization as vice president of external affairs and strategic integration on December 1, 2008.

In this role, Mr. Heyman will be responsible for developing and implementing external affairs strategies for USP that support its mission of improving health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. He will manage outreach to USP's many external constituencies, which include members of the USP Convention, government agencies, international organizations, other standards-setting groups, health care practitioners, news media and the public. Mr. Heyman will oversee USP's government relations, public relations/corporate communications, marketing communications and member and professional relations functions in this newly created position. He will be responsible for creating integrated outreach programs that align with and promote USP's priorities.

Mr. Heyman has more than 30 years of leadership experience in science and technology policy and program management, communications, public affairs and government and business relations. He most recently served as chief of staff at the National Institute of Standards and Technology (NIST), directing and overseeing the strategic planning, evaluation and external affairs activities of an agency that works to improve U.S. innovation, trade, security and health and safety. In this role, he led agency interactions with Members of Congress and other policy makers, news media, the public and others.

Before assuming the role of chief of staff in 2003, Mr. Heyman held a number of high-level positions within NIST and its parent agency, the U.S. Department of Commerce. For more than a decade, he was chief of public and business affairs at NIST, directing its communications activities through many high-profile projects including the federal building and fire investigation of the 9/11 World Trade Center tragedy. Previously, he was communications advisor to the deputy secretary of the Department of Commerce; acting director of public affairs for the Technology Administration at the Department of Commerce; and chief of media liaison at NIST, which was the National Bureau of Standards at the time. He began his career as a reporter and editor for several engineering magazines.

"We are very pleased to have Mat join USP's senior management team," said Roger L. Williams, M.D., USP executive vice president and CEO. "His broad range of experience and expertise in science and technology areas will be a major asset to USP as the organization continues to expand its activities to improve the health of patients worldwide through good quality medicines, dietary supplements and food ingredients. I look forward to working with him as we strive to positively impact national and international public health."
Mr. Heyman holds a master's degree in science, technology and public policy from the George Washington University and a bachelor's degree in environmental studies and English from the State University of New York, Albany.

USP--Advancing Public Health Since 1820
The United States Pharmacopeial (USP) Convention is a private, non-profit, standards-setting organization that advances public health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP's standards are recognized and used worldwide. For more information about USP visit FY0919

Laura Provan


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. KGI Names Kerry Howell Vice President for Advancement
2. Vical Names Andrew de Guttadauro Vice President, Corporate Development
3. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
4. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
5. CryoLife Names Philip Theodore as Vice President, General Counsel
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. PPD Names Daniel Darazsdi as Chief Financial Officer
8. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
9. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
10. Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
11. Osprey Pharmaceuticals Names Jack M. Anthony as CEO
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
Breaking Biology News(10 mins):